TY - JOUR
T1 - Maternal and paternal depression symptoms during NICU stay and transition home
AU - Garfield, Craig F.
AU - Lee, Young S.
AU - Warner-Shifflett, Liam
AU - Christie, Rebecca
AU - Jackson, Kathryn L.
AU - Miller, Emily
N1 - Funding Information:
The authors acknowledge Friends of Prentice for a generous grant to conduct this research. The funders did not influence in any way the outcomes or reporting of the find ings in this study.
Publisher Copyright:
Copyright © 2021 by the American Academy of Pediatrics
PY - 2021/8/1
Y1 - 2021/8/1
N2 - OBJECTIVE: To examine the trajectory and risk factors of depression symptoms among parents from NICU admission to 30 days postdischarge. We hypothesized depression symptom scores would decrease from admission and then increase from discharge to 30 days. METHODS: Prospective longitudinal cohort study of premature infants in NICU. Parents completed the validated Edinburgh Postnatal Depression Scale (EPDS) at 4 time points: NICU admission, discharge, and 14 days and 30 days postdischarge. EPDS score change across time and probability of a positive screen (EPDS $10) were by assessed using mixed effect regression models. RESULTS: Of 431 parents enrolled (mothers, n 5 230 [53%]), 33% of mothers (n 5 57) and 17% of fathers (n 5 21) had a positive EPDS screening. Score change was 1.9 points different between mothers and fathers (confidence interval [CI]: 1.3–2.6; P < .0001), with mothers decreasing 2.9 points (CI: 2.1–3.7; P < .0001) and fathers decreasing 1.0 points (CI: 0.1–2.0; P 5 .04). Over time, mothers decreased 10.96 times (CI: 2.99–38.20; P 5 .0003); fathers decreased at a nonsignificant rate. Admission or discharge screening improved 30-day depressive symptom prediction (AUC 0.66 baseline demographics only versus 0.841initial [P < .0001], and versus 0.801discharge screening [P < .001]). CONCLUSIONS: Mothers and fathers experience different depressive symptom trajectories from NICU to home. Screening parents for postpartum depression during the NICU stay is likely to result in improved identification of parents at risk for postpartum depression after discharge. Focused attention on fathers appears warranted.
AB - OBJECTIVE: To examine the trajectory and risk factors of depression symptoms among parents from NICU admission to 30 days postdischarge. We hypothesized depression symptom scores would decrease from admission and then increase from discharge to 30 days. METHODS: Prospective longitudinal cohort study of premature infants in NICU. Parents completed the validated Edinburgh Postnatal Depression Scale (EPDS) at 4 time points: NICU admission, discharge, and 14 days and 30 days postdischarge. EPDS score change across time and probability of a positive screen (EPDS $10) were by assessed using mixed effect regression models. RESULTS: Of 431 parents enrolled (mothers, n 5 230 [53%]), 33% of mothers (n 5 57) and 17% of fathers (n 5 21) had a positive EPDS screening. Score change was 1.9 points different between mothers and fathers (confidence interval [CI]: 1.3–2.6; P < .0001), with mothers decreasing 2.9 points (CI: 2.1–3.7; P < .0001) and fathers decreasing 1.0 points (CI: 0.1–2.0; P 5 .04). Over time, mothers decreased 10.96 times (CI: 2.99–38.20; P 5 .0003); fathers decreased at a nonsignificant rate. Admission or discharge screening improved 30-day depressive symptom prediction (AUC 0.66 baseline demographics only versus 0.841initial [P < .0001], and versus 0.801discharge screening [P < .001]). CONCLUSIONS: Mothers and fathers experience different depressive symptom trajectories from NICU to home. Screening parents for postpartum depression during the NICU stay is likely to result in improved identification of parents at risk for postpartum depression after discharge. Focused attention on fathers appears warranted.
UR - http://www.scopus.com/inward/record.url?scp=85113505025&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113505025&partnerID=8YFLogxK
U2 - 10.1542/peds.2020-042747
DO - 10.1542/peds.2020-042747
M3 - Article
C2 - 34341101
AN - SCOPUS:85113505025
SN - 0031-4005
VL - 148
JO - Pediatrics
JF - Pediatrics
IS - 2
M1 - 042747
ER -